XML 32 R23.htm IDEA: XBRL DOCUMENT v3.23.2
SHARE CAPITAL AND OTHER EQUITY INSTRUMENTS (Tables)
6 Months Ended
Jun. 30, 2023
Equity [Abstract]  
SCHEDULE OF STOCK OPTION

A summary of activity under the Company’s incentive plan for the six months ended June 30, 2023, is presented below:

 

    Number of Shares   Weighted Average Exercise Price   Weighted Average Grant Date Fair Value   Weighted Average Remaining Contractual Term (years)   Aggregate Intrinsic Value 
Outstanding at December 31, 2022    48,329   $37.05   $44.82    4.1   $ 
Forfeited    (11,750)  $3.07   $2.58       $ 
Outstanding at June 30, 2023    36,579   $47.93   $64.47    3.6   $ 
Exercisable at June 30, 2023    28,265   $56.59   $76.86    3.2   $ 
SCHEDULE OF RESTRICTED STOCK UNITS AND AWARDS ACTIVITY

The Company’s activity in restricted stock units was as follows for the six months ended June 30, 2023:

 

    Number of shares   Weighted average fair value 
Non-vested at December 31, 2022    64,053   $92.57 
Granted    182,500   $2.73 
Vested    (57,280)  $8.93 
Forfeited    (9,158)  $44.69 
Non-vested at June 30, 2023    180,115   $30.57 
SCHEDULE OF STOCK-BASED COMPENSATION FOR RESTRICTED STOCK UNITS

The following table summarizes the Company’s recognition of stock-based compensation for restricted stock units for the following periods:

  

   2023   2022   2023   2022 
   Three months ended June 30,   Six months ended June 30, 
   2023   2022   2023   2022 
Stock-based compensation expense for RSUs:                    
General and administrative  $592,929   $358,818   $845,244   $717,636 
Research and development   232,434    263,778    464,868    624,727 
Total  $825,363   $622,596   $1,310,112   $1,342,363 
SCHEDULE OF WARRANTS OUTSTANDING

The following table summarizes information about shares issuable under warrants outstanding on June 30, 2023:

 

   Warrant shares outstanding   Weighted average exercise price   Weighted average remaining life   Intrinsic value 
Outstanding at December 31, 2022   655,463   $58.36    3.6   $5,514 
Outstanding at June 30, 2023   655,463   $58.36    3.1   $ 
Exercisable at June 30, 2023   655,463   $58.36    3.1   $ 
SCHEDULE OF WARRANTS AND INVESTMENT OPTIONS

The following table summarizes information about investment options outstanding on June 30, 2023:

 

 

ENVERIC BIOSCIENCES, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

   Investment options outstanding   Weighted average exercise price   Weighted average remaining life   Intrinsic value 
Outstanding at December 31, 2022   1,070,000   $7.93    5.1   $ 
Outstanding at June 30, 2023   1,070,000   $7.93    4.6   $ 
Exercisable at June 30, 2023   1,070,000   $7.93    4.6   $